CD8A and hepatocellular carcinoma: Conversely, during the transition from MASH to HCC, hepatic lipid accumulation may exacerbate DC impairment by enhancing triglyceride uptake via scavenger receptor A, thereby compromising tumor-specific antigen presentation to CD8+ T cells and anti-tumor immune responses (89).